All News
46 articles in total
Clinical Frontier SARMs Series: Innovative Research Tools Advancing Muscle Disease Treatments
In the pharmaceutical and biomedical research fields, clinical frontier SARMs (such as PF-06260414, GSK-2881078, and GLPG0492), as selective androgen receptor modulators that have entered clinical trials, represent potential breakthroughs in treating muscle wasting and metabolic diseases. PHMO is committed to supplying the highest purity cutting-edge research materials, supporting your innovative R&D projects and facilitating the transition from lab to clinic.
AC Series SARMs: New Advances in Non-Steroidal, Muscle-Selective Research Tools
In the field of anabolic research, non-steroidal Selective Androgen Receptor Modulators (SARMs) have attracted significant attention due to their potential tissue selectivity. The AC series SARMs, such as AC-262536 and AC-262,356, represent a new generation of research compounds designed to explore the mechanisms of muscle growth and strength enhancement while minimizing the side effects associated with traditional androgen therapies. PHMO supplies high-purity AC series raw materials, providing reliable support for your preclinical research and drug development projects.
MK Series SARMs: Advanced Tools for Exploring Muscle Protection and Tissue-Selective Research
In the field of selective androgen receptor modulator research, MK series compounds (such as MK-0773 and MK-4541) represent significant progress from muscle health studies to tissue-specific therapeutic exploration. MK-0773, a steroidal SARM that has entered Phase II clinical studies, provides a reference model for sarcopenia and osteoporosis research from preclinical to clinical stages. MK-4541 demonstrates potential in research for differentially modulating muscle anabolism and prostate tissue. PHMO supports your complete research pipeline from basic science to translational medicine with high-purity, compliant research materials.
LGD Series SARMs: Precision Research Tools for Exploring Muscle and Bone Metabolism
In the fields of sports nutrition and pharmaceutical research, LGD series SARMs (such as LGD-3303 and LGD-2226), as experimental selective androgen receptor modulators, offer a potential tissue-selective approach for research into muscle wasting and osteoporosis. PHMO is committed to supplying high-purity research materials to empower your R&D projects.
SARMs: The Potential and Controversy of Selective Androgen Receptor Modulators
Selective androgen receptor modulators (SARMs) are emerging as one of the most promising drug candidates for the treatment of muscle atrophy, osteoporosis, and cancer cachexia. Compared to traditional synthetic androgens, SARMs aim to retain potent anabolic effects while significantly reducing androgen-related side effects. This article, drawing on cutting-edge research, provides an in-depth analysis of the scientific nature, research progress, and practical challenges of SARMs.
Empowering Scalp Regeneration: How PHMO Peptide APIs Restart Hair Growth from the Microenvironment
At the forefront of hair growth science, PHMO's Peptide Adjuvant ingredients represent a paradigm shift from "treating symptoms" to "rebuilding health." Our copper peptides do not directly block or aggressively stimulate; instead, they focus on repairing the scalp microenvironment, creating the optimal foundation for follicle regeneration.